Scott J Moeller1, Adam W Hanley2,3, Eric L Garland2,3. 1. Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, NY. 2. University of Utah Center on Mindfulness and Integrative Health Intervention Development, Salt Lake City, UT. 3. College of Social Work, University of Utah, Salt Lake City, UT.
Abstract
BACKGROUND: The USA is currently enduring an opioid crisis. Identifying cost-effective, easy-to-implement behavioral measures that predict treatment outcomes in opioid misusers is a crucial scientific, therapeutic, and epidemiological goal. METHODS: The current study used a mixed cross-sectional and longitudinal design to test whether a behavioral choice task, previously validated in stimulant users, was associated with increased opioid misuse severity at baseline, and whether it predicted change in opioid misuse severity at follow-up. At baseline, data from 100 prescription opioid-treated chronic pain patients were analyzed; at follow-up, data were analyzed in 34 of these participants who were non-misusers at baseline. During the choice task, participants chose under probabilistic contingencies whether to view opioid-related images in comparison with affectively pleasant, unpleasant, and neutral images. Following previous procedures, we also assessed insight into choice behavior, operationalized as whether (yes/no) participants correctly self-reported the image category they chose most often. RESULTS: At baseline, the higher choice for viewing opioid images in direct comparison with pleasant images was associated with opioid misuse and impaired insight into choice behavior; the combination of these produced especially elevated opioid-related choice behavior. In longitudinal analyses of individuals who were initially non-misusers, higher baseline opioid v. pleasant choice behavior predicted more opioid misuse behaviors at follow-up. CONCLUSIONS: These results indicate that greater relative allocation of behavior toward opioid stimuli and away from stimuli depicting natural reinforcement is associated with concurrent opioid misuse and portends vulnerability toward future misuse. The choice task may provide important medical information to guide opioid-prescribing practices.
BACKGROUND: The USA is currently enduring an opioid crisis. Identifying cost-effective, easy-to-implement behavioral measures that predict treatment outcomes in opioid misusers is a crucial scientific, therapeutic, and epidemiological goal. METHODS: The current study used a mixed cross-sectional and longitudinal design to test whether a behavioral choice task, previously validated in stimulant users, was associated with increased opioid misuse severity at baseline, and whether it predicted change in opioid misuse severity at follow-up. At baseline, data from 100 prescription opioid-treated chronic painpatients were analyzed; at follow-up, data were analyzed in 34 of these participants who were non-misusers at baseline. During the choice task, participants chose under probabilistic contingencies whether to view opioid-related images in comparison with affectively pleasant, unpleasant, and neutral images. Following previous procedures, we also assessed insight into choice behavior, operationalized as whether (yes/no) participants correctly self-reported the image category they chose most often. RESULTS: At baseline, the higher choice for viewing opioid images in direct comparison with pleasant images was associated with opioid misuse and impaired insight into choice behavior; the combination of these produced especially elevated opioid-related choice behavior. In longitudinal analyses of individuals who were initially non-misusers, higher baseline opioid v. pleasant choice behavior predicted more opioid misuse behaviors at follow-up. CONCLUSIONS: These results indicate that greater relative allocation of behavior toward opioid stimuli and away from stimuli depicting natural reinforcement is associated with concurrent opioid misuse and portends vulnerability toward future misuse. The choice task may provide important medical information to guide opioid-prescribing practices.
Authors: Anthony S David; Nicholas Bedford; Ben Wiffen; James Gilleen Journal: Philos Trans R Soc Lond B Biol Sci Date: 2012-05-19 Impact factor: 6.237
Authors: Kristen P Lindgren; Clayton Neighbors; Melissa L Gasser; Jason J Ramirez; Dario Cvencek Journal: Am J Drug Alcohol Abuse Date: 2016-10-07 Impact factor: 3.829
Authors: Scott J Moeller; Muhammad A Parvaz; Elena Shumay; Nicasia Beebe-Wang; Anna B Konova; Nelly Alia-Klein; Nora D Volkow; Rita Z Goldstein Journal: J Neurosci Date: 2013-06-12 Impact factor: 6.167
Authors: Eric L Garland; Eron G Manusov; Brett Froeliger; Amber Kelly; Jaclyn M Williams; Matthew O Howard Journal: J Consult Clin Psychol Date: 2014-02-03
Authors: Kevin E Vowles; Mindy L McEntee; Peter Siyahhan Julnes; Tessa Frohe; John P Ney; David N van der Goes Journal: Pain Date: 2015-04 Impact factor: 6.961
Authors: Scott J Moeller; Prantik Kundu; Keren Bachi; Thomas Maloney; Pias Malaker; Muhammad A Parvaz; Nelly Alia-Klein; Edythe D London; Rita Z Goldstein Journal: Drug Alcohol Depend Date: 2020-02-28 Impact factor: 4.492
Authors: Paul W Glimcher; Anna B Konova; Kathryn Biernacki; Silvia Lopez-Guzman; John C Messinger; Nidhi V Banavar; John Rotrosen Journal: Neuropsychopharmacology Date: 2021-12-16 Impact factor: 8.294